Skip to main content
. 2023 Feb 27;82(4):283–295. doi: 10.1093/jnen/nlad015

Table 3.

Neuropathological findings

Patient no. SARS-CoV-2 pango lineage Symptom onset to death (days) Postmortem interval (h) Brain weight (g) COVID-19-associated neuropathological findings
1 A.2 21 52 1290 Mild hypoxic ischemic injury
2 B.1 9 40 1460 Mild hypoxic ischemic injury
3 B.1 8 20 1530 Mild hypoxic ischemic injury
4 B.1.2 24 10 1590 Mild hypoxic ischemic injury
5 B.1.2 13 116 1380 Scattered petechial/microhemorrhages; acute microinfarct in inferior olivary nucleus; mild hypoxic ischemic injury
6 AY.86 (Delta) 4 41 1460 Focal subarachnoid hemorrhage; mild to moderate hypoxic ischemic injury
7 AY.119 (Delta) 32 50 1580 Scattered microinfarcts with hemorrhage involving white matter throughout brain; focal microglial nodule formation in medulla; mild hypoxic ischemic injury
8 AY.47 (Delta) 22 58 1370 Mild hypoxic ischemic injury
9 Unknown (presumed Delta)a 22 43 1260 Chronic microinfarct in corpus callosum; mild hypoxic ischemic injury
10 AY.117 (Delta) 9 30 1210 Mild hypoxic ischemic injury
11 Unknown (presumed Delta)a 1 122 1290 Mild hypoxic ischemic injury
12 AY.3 (Delta) 50 8 1020 Mild hypoxic ischemic injury
13 Unknown (presumed Delta)a 8 180 1250 Subdural hemorrhage; mild hypoxic ischemic injury
14 Unknown (presumed Delta)a 18 45 1390 Single microglial nodule in medulla; mild hypoxic ischemic injury
15 AY.119 (Delta) 33 11 1220 Mild hypoxic ischemic injury
16 B.1.617.2 (Delta) 17 72 1430 Mild hypoxic ischemic injury
17 AY.25 (Delta) 7 20 1360 Mild hypoxic ischemic injury; red blood cell extravasation
18 BA.1.1 (Omicron) 9 96 1380 Mild hypoxic ischemic injury
19 BA.1.15 (Omicron) 6 69 1280 None
20 BA.1 (Omicron) 6 65 1180 Mild hypoxic ischemic injury
21 BA.1.1 (Omicron) 3 72 1100 Parenchymal microhemorrhages; subarachnoid hemorrhage; mild hypoxic ischemic injury
22 Unknown (presumed Omicron)a 29 121 1150 Mild hypoxic ischemic injury
a

SARS-CoV-2 variant not confirmed by sequencing of lung tissue or nasopharyngeal swabs. These cases were assigned to Delta variant cohort if first reported COVID-19 symptoms or positive RT-PCR test were between July 1 and December 15, 2021 or to Omicron cohort if first reported symptoms or positive RT-PCR test were from December 16, 2021 to February 15, 2022.